These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8436740)

  • 21. Safety of thrombolytic therapy in elderly patients with massive pulmonary embolism: a comparison with nonelderly patients.
    Meneveau N; Bassand JP; Schiele F; Bouras Y; Anguenot T; Bernard Y; Schultz R
    J Am Coll Cardiol; 1993 Oct; 22(4):1075-9. PubMed ID: 8409043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction. TAMI Study Group.
    Kereiakes DJ; Califf RM; George BS; Ellis S; Samaha J; Stack R; Martin LH; Young S; Topol EJ
    Am Heart J; 1991 Aug; 122(2):390-9. PubMed ID: 1907087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolytic therapy in acute myocardial infarction.
    Rutherford JD; Braunwald E
    Chest; 1990 Apr; 97(4 Suppl):136S-145S. PubMed ID: 2108851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleeding after thrombolysis in acute myocardial infarction.
    Erlemeier HH; Zangemeister W; Burmester L; Schofer J; Mathey DG; Bleifeld W
    Eur Heart J; 1989 Jan; 10(1):16-23. PubMed ID: 2702962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis.
    Mikkola KM; Patel SR; Parker JA; Grodstein F; Goldhaber SZ
    Am Heart J; 1997 Jul; 134(1):69-72. PubMed ID: 9266785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
    Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
    Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous thrombolytic therapy with a combination of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Bode C; Schuler G; Nordt T; Schönermark S; Baumann H; Richardt G; Dietz R; Gurewich V; Kübler W
    Circulation; 1990 Mar; 81(3):907-13. PubMed ID: 2106403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular basis of thrombolysis and its clinical application in stroke.
    Murray V; Norrving B; Sandercock PA; Terént A; Wardlaw JM; Wester P
    J Intern Med; 2010 Feb; 267(2):191-208. PubMed ID: 20175866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D; Bounameaux H
    Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.
    Collen D; Van de Werf F
    Am J Cardiol; 1987 Sep; 60(7):431-4. PubMed ID: 3115077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group.
    Stump DC; Califf RM; Topol EJ; Sigmon K; Thornton D; Masek R; Anderson L; Collen D
    Circulation; 1989 Nov; 80(5):1222-30. PubMed ID: 2509104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinase.
    Morris JA; Muller DW; Topol EJ
    Am Heart J; 1991 Aug; 122(2):375-80. PubMed ID: 1907086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary reperfusion studies with pro-urokinase in acute myocardial infarction: evidence for synergism of low dose urokinase.
    Kasper W; Hohnloser SH; Engler H; Meinertz T; Wilkens J; Roth E; Lang K; Limbourg P; Just H
    J Am Coll Cardiol; 1990 Sep; 16(3):733-8. PubMed ID: 2117622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction.
    Ohman EM; Christenson RH; Califf RM; George BS; Samaha JK; Kereiakes DJ; Worley SJ; Wall TC; Berrios E; Sigmon KN
    Am Heart J; 1993 Oct; 126(4):819-26. PubMed ID: 8213437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.
    Muller DW; Topol EJ; Ellis SG; Sigmon KN; Lee K; Califf RM
    Am Heart J; 1991 Apr; 121(4 Pt 1):1042-9. PubMed ID: 1901190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of reperfusion strategies in the treatment of patients with acute myocardial infarction.
    Faxon DP
    J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):52A-57A. PubMed ID: 2973488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolytic therapy.
    Collen D; Stump DC; Gold HK
    Annu Rev Med; 1988; 39():405-23. PubMed ID: 3130773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.